Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Acquisition of Nightstar Therapeutics by Biogen

Nightstar Therapeutics was acquired by Biogen for $800 million.

OverviewStructured DataIssuesContributorsActivity

The acquisition of Nightstar Therapeutics was announced by its acquirer, Biogen, on March 4, 2019, and completed on June 7, 2019, for a total cost of $800 million. The acquisition resulted in the Nightstar stock being removed from the Nasdaq Global Select Market.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Acquisition of Nightstar Therapeutics by Biogen

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo